Avecho Biotechnology Ltd News

Avecho Biotechnology Ltd: 2024 Annual General Meeting Results

May 30 13:29

Avecho Biotechnology Ltd: Chair's Address and CEO Presentation

May 30 10:37

Avecho Biotechnology Ltd: Notification of cessation of securities - AVE

May 21 08:48

Avecho Biotechnology Ltd: First Patient dosed in Phase III insomnia trial

May 16 07:09

Avecho Biotechnology Ltd: March 2024 Quarterly Activities Report & Appendix 4C

Apr 30 07:53

Avecho Biotechnology Ltd: Initial Director's Interest Notice

Apr 26 09:49

Avecho Biotechnology Ltd: Notice of Annual General Meeting/Proxy Form

Apr 26 07:55

Avecho Biotechnology Ltd: Notification regarding unquoted securities - AVE

Apr 26 07:48

Avecho Biotechnology Ltd: Appointment of New Director

Apr 26 07:34

Avecho Biotechnology Ltd: Monash Sleep Health Symposium

Apr 22 07:23

Avecho Biotechnology Ltd: Avecho commences Phase III insomnia trial

Mar 26 05:31

Avecho Biotechnology Ltd: Avecho to present at NWR Virtual Healthcare Conference

Mar 18 06:24

Avecho Biotechnology Ltd: Avecho meets TGA ahead of Phase III Clinical Trial

Mar 14 07:25

Avecho Biotechnology Ltd: AVE receives final ethics approval for Phase III CBD trial

Mar 7 06:31

Avecho Biotechnology Ltd: Appendix 4G and Corporate Governance Statement

Feb 29 14:42

Avecho Biotechnology Ltd: Appendix 4E and Annual Report 31 December 2023

Feb 29 14:34

Avecho Biotechnology Ltd: December 2023 Quarterly Activities Report & Appendix 4C

Jan 31 05:50

Avecho Biotechnology Ltd: Expiry of Quoted Options

Nov 28, 2023 06:41

Avecho Biotechnology Ltd: Change of Director's Interest Notice x2

Nov 23, 2023 10:27

Avecho Biotechnology Ltd: Application for quotation of securities - AVE

Nov 22, 2023 10:03